中新网北京4月21日电 (付宁)北京亦庄，这片位于北京经济技术开发区的生物医药产业热土，正日益展现出“新药智造”产业高地的强劲活力。据统计，截至目前，该区域的生物医药企业已超过4200家，其中不乏高新技术企业和“专精特新”企业，总数达到百余家，彰显出其在创新领域的深厚底蕴和勃勃生机。
据最新数据显示，北京亦庄的生物医药产业集群中，近百款自主研发的创新药物及医疗器械正处于临床试验和申报上市的关键阶段，这一数字标志着北京亦庄在新药研发和高端医疗器械制造方面取得了显著的突破。这些新药和器械的涌现，不仅为疾病的治疗提供了更多可能性，也为我国生物医药产业的创新驱动发展注入了新的动力。
北京亦庄“新药智造”产业高地行动的实施，旨在打造全球领先的生物医药创新中心，通过优化政策环境、强化科技支撑和提升服务能力，为企业发展提供了良好的土壤。随着越来越多的创新型企业在此聚集，北京亦庄正逐步构建起完整的生物医药产业链，有力推动了区域经济的高质量发展。
未来，北京亦庄将继续秉持创新驱动的发展理念，加强与国内外科研机构的合作，吸引更多高端人才，致力于将“新药智造”产业高地打造成为全球生物医药产业的璀璨明珠。
英语如下：
**News Title:** “Beijing Yizhuang Forges a ‘New Drug Manufacturing’ Hub, with Over 4,200 Biopharmaceutical Companies Driving Innovation Wave”
**Keywords:** Beijing Yizhuang, New Drug Manufacturing, Industry Hub
**News Content:**
**BEIJING, April 21 (China News Service) -** Beijing Yizhuang, a thriving biopharmaceutical industry hub located in Beijing’s Economic and Technological Development Area, is demonstrating remarkable progress in building its “New Drug Manufacturing” sector. To date, the region is home to over 4,200 biopharmaceutical companies, including numerous high-tech enterprises and “specialized, refined, novel, and innovative” (SRNI) firms, with a total of over a hundred, showcasing its strong foundation and vitality in innovation.
Latest statistics reveal that nearly 100 self-developed innovative drugs and medical devices in Beijing Yizhuang’s biopharmaceutical cluster are currently in crucial stages of clinical trials and awaiting approval for market entry. This figure underscores the significant strides made by Beijing Yizhuang in new drug research and development and high-end medical device manufacturing. These novel drugs and devices promise more treatment options for diseases and infuse fresh impetus into China’s biopharmaceutical industry driven by innovation.
The implementation of the “New Drug Manufacturing” industry高地 initiative in Beijing Yizhuang aims to establish a globally leading biopharmaceutical innovation center. By optimizing policy environment, strengthening technological support, and enhancing service capabilities, it fosters a conducive environment for enterprise growth. As more innovative companies converge in the area, Beijing Yizhuang is gradually constructing a comprehensive biopharmaceutical industry chain, significantly contributing to the region’s high-quality economic development.
Looking ahead, Beijing Yizhuang will adhere to the principle of innovation-driven development, strengthen collaborations with domestic and international research institutions, attract top talent, and endeavor to transform its “New Drug Manufacturing” hub into a brilliant jewel in the global biopharmaceutical industry.
【来源】http://www.chinanews.com/cj/2024/04-21/10203093.shtml
Views: 1